Mild cognitive impairment in Parkinson's disease
Dag Aarsland1, Kolbjørn Brønnick, Tormod Fladby
1Centre for Age-Related Diseases, Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway. daarsland@gmail.com
Current Neurology and Neuroscience Reports
|April 14, 2011
Summary
Most Parkinson's disease (PD) patients develop dementia. A significant portion of PD patients, even at diagnosis, exhibit mild cognitive impairment (PD-MCI), which predicts faster progression to dementia.
Area of Science:
- Neurology
- Cognitive Science
Background:
- Prospective studies indicate most Parkinson's disease (PD) patients develop dementia.
- Recent research highlights mild cognitive impairment (PD-MCI) in approximately 25% of PD patients without dementia.
- Around 20% of PD patients present with MCI at the time of diagnosis.
Purpose of the Study:
- To review the prevalence and characteristics of mild cognitive impairment in Parkinson's disease.
- To explore the potential etiological factors contributing to PD-MCI.
- To discuss the prognostic implications of PD-MCI for dementia development.
Main Methods:
- Review of prospective studies and recent research on cognitive impairment in Parkinson's disease.
- Analysis of typical cognitive deficits observed in PD-MCI.
- Discussion of potential etiological mechanisms.
Main Results:
- PD-MCI is characterized by visuospatial, attentional, executive, and sometimes memory deficits.
- Etiology likely involves Lewy bodies, amyloid plaques, cholinergic deficits, and frontostriatal circuit dysfunction.
- PD-MCI is a predictor of accelerated progression to dementia, especially with posterior cognitive deficits.
Conclusions:
- Mild cognitive impairment is a common finding in Parkinson's disease, often present at diagnosis.
- Understanding PD-MCI etiology is crucial for potential interventions.
- PD-MCI signifies an increased risk for developing dementia in Parkinson's disease patients.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...